TransThera Presents Key Phase II Data for Tenvogotinib in FGFR Inhibitor–Pretreated Advanced Biliary Tract Cancer at ASCO 2026
May 31, 2026 18:08
CST Updated
18:28
TransThera
Small Molecule Innovative Drug Research, Development, and Manufacturing